Jane Street Portfolio holdings
Jane Street Group, founded in 2000 by Tim Reynolds, Rob Granieri, Marc Gerstein, and Michael Jenkins, is a New York City-based quantitative trading firm renowned for its technological prowess and collaborative problem-solving culture. Specializing in liquidity provision and market-making, it trades a vast array of financial products—including equities, bonds, options, and ETFs—across over 200 venues in 45 countries, handling trillions in securities annually. The firm, which employs over 2,600 people across offices in New York, London, Hong Kong, Amsterdam, Chicago, and Singapore, leverages advanced algorithms and a nearly 70-million-line OCaml codebase to dominate markets, notably ETFs, where it plays a critical role as an authorized participant. With net trading revenues exceeding $10 billion annually in recent years, including a record $10.6 billion in 2023, Jane Street has emerged as a secretive yet powerful force in global finance, outpacing traditional Wall Street giants like Goldman Sachs in trading profitability.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI Emerging Markets ETF
EEM
|
+$229M |
| 2 |
VanEck Gold Miners ETF
GDX
|
+$213M |
| 3 |
KMP
KINDER MORGAN ENER PNTRS L.P.
KMP
|
+$81.1M |
| 4 |
Procter & Gamble
PG
|
+$75.6M |
| 5 |
iShares JPMorgan USD Emerging Markets Bond ETF
EMB
|
+$61.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AstraZeneca
AZN
|
+$127M |
| 2 |
BP
BP
|
+$71M |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$64M |
| 4 |
SLB Ltd
SLB
|
+$54.4M |
| 5 |
iShares Core MSCI Emerging Markets ETF
IEMG
|
+$46.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Energy | 3.32% |
| 2 | Technology | 3.01% |
| 3 | Communication Services | 2.63% |
| 4 | Consumer Discretionary | 2.61% |
| 5 | Financials | 2.25% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
OREX
2351
DELISTED
Orexigen Therapeutics, Inc.
OREX
| $104K | ﹤0.01% |
2,442
-11,543
| -83% | -$620K |
|
2352
Accuray
ARAY
$32M
| $103K | ﹤0.01% |
+14,157
| New | +$115K |
|
2353
Ezcorp Inc
EZPW
$1.83B
| $102K | ﹤0.01% |
+10,266
| New | +$106K |
|
2354
SiriusXM
SIRI
$9.98B
| $101K | ﹤0.01% |
2,894
-11,716
| -80% | -$410K |
|
|
WLT
2355
PUT
DELISTED
WALTER ENERGY INC COM STK (DE)
WLT
| $101K | ﹤0.01% |
+43,200
| New | +$223K |
|
|
GFIG
2356
DELISTED
GFI GROUP INC
GFIG
| $101K | ﹤0.01% |
18,752
-10,410
| -36% | -$45.7K |
|
|
ATRS
2357
DELISTED
Antares Pharma, Inc.
ATRS
| $98K | ﹤0.01% |
+53,668
| New | +$117K |
|
|
HIVE
2358
DELISTED
Aerohive Networks
HIVE
| $98K | ﹤0.01% |
12,184
-4,341
| -26% | -$35.8K |
|
2359
EyePoint Inc
EYPT
$1.03B
| $97K | ﹤0.01% |
2,198
-12,234
| -85% | -$551K |
|
2360
FormFactor
FORM
$8.28B
| $93K | ﹤0.01% |
12,985
-16,446
| -56% | -$122K |
|
2361
Travere Therapeutics
TVTX
$5.2B
| $93K | ﹤0.01% |
+10,280
| New | +$121K |
|
|
ENSV
2362
DELISTED
Enservco Corp.
ENSV
| $93K | ﹤0.01% |
1,698
-1,969
| -54% | -$95K |
|
2363
Rigel Pharmaceuticals
RIGL
$681M
| $91K | ﹤0.01% |
+4,713
| New | +$133K |
|
2364
Paramount Gold Nevada
PZG
$96.1M
| $89K | ﹤0.01% |
98,626
+2,934
| +3% | +$2.86K |
|
|
SGL
2365
DELISTED
STRATEGIC GLOBAL INCOME FUND
SGL
| $89K | ﹤0.01% |
+10,061
| New | +$91.8K |
|
|
DVAX
2366
DELISTED
Dynavax Technologies
DVAX
| $88K | ﹤0.01% |
6,124
+4,801
| +363% | +$69.2K |
|
|
YGE
2367
DELISTED
Yingli Green Energy Holding Comp
YGE
| $87K | ﹤0.01% |
2,791
+1,696
| +155% | +$58.7K |
|
|
AGEN
2368
Agenus
AGEN
$312M
| $85K | ﹤0.01% |
1,399
-7,003
| -83% | -$439K |
|
|
FULL
2369
DELISTED
Full Circle Capital Corporation
FULL
| $85K | ﹤0.01% |
13,295
-1,728
| -12% | -$12.7K |
|
|
LKM
2370
CALL
DELISTED
Link Motion Inc.
LKM
| $84K | ﹤0.01% |
+12,000
| New | +$73.5K |
|
|
PLNR
2371
DELISTED
PLANAR SYSTEMS INC
PLNR
| $84K | ﹤0.01% |
+22,077
| New | +$80.6K |
|
|
DNDN
2372
DELISTED
DENDREON CORPORATION
DNDN
| $84K | ﹤0.01% |
+58,253
| New | +$102K |
|
2373
Protalix BioTherapeutics
PLX
$191M
| $82K | ﹤0.01% |
3,405
+1,962
| +136% | +$56.5K |
|
|
OTIV
2374
DELISTED
OTI On Track Innovations Ltd
OTIV
| $82K | ﹤0.01% |
+29,430
| New | +$75.1K |
|
|
GIGA
2375
DELISTED
Giga-Tronics Inc
GIGA
| $82K | ﹤0.01% |
40,870
+26,803
| +191% | +$56.7K |
|
Similar funds
Jane Street's Q3 2014 Portfolio in Review
As of Q3 2014, Jane Street held 3,618 positions worth $9.81B, up 25% from $7.86B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Jane Street deployed $2.23B of net new capital in Q3 2014, opening 1,130 new positions and adding to 681 existing holdings. Its largest new stake was iShares MSCI Emerging Markets ETF: 5,183,984 shares worth $215M.
By sector, the portfolio is most concentrated in Energy at 3.3% of assets, down from 4.3% a quarter earlier, followed by Technology and Communication Services.
On the sell side, the largest reduction was AstraZeneca, an estimated $127M trimmed.
- Jane Street's largest Q3 2014 buy was iShares MSCI Emerging Markets ETF: 5,183,984 shares worth $215M.
- Jane Street added most to KINDER MORGAN ENER PNTRS L.P. in Q3 2014, an estimated $81.1M increase.
- Jane Street's biggest Q3 2014 reduction was AstraZeneca, cutting an estimated $127M.
- Jane Street fully exited BP in Q3 2014, selling an estimated $71M.
- Jane Street's ten largest holdings make up 23% of its $9.81B portfolio in Q3 2014.
- Jane Street opened 1,130 new positions and closed 1,133 in Q3 2014.
- Jane Street's portfolio value rose 25% quarter-over-quarter to $9.81B.
Based on Jane Street's 13F filing for Q3 2014, filed 14 Nov 2014.